4//SEC Filing
Ostertag Eric 4
Accession 0001209191-21-060403
CIK 0001661460other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 6:59 PM ET
Size
12.0 KB
Accession
0001209191-21-060403
Insider Transaction Report
Form 4
Ostertag Eric
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Stock
2021-10-11$9.15/sh+18,525$169,504→ 696,422 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-10-11−18,525→ 740,995 totalExercise: $9.15Exp: 2031-02-03→ Common Stock (18,525 underlying)
Holdings
- 3,669,376(indirect: See footnote)
Common Stock
- 961,445(indirect: See footnote)
Common Stock
- 3,367,506(indirect: See footnote)
Common Stock
- 160,696(indirect: See footnote)
Common Stock
- 629,194(indirect: See footnote)
Common Stock
Footnotes (7)
- [F1]Includes 2,482 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on September 20, 2021.
- [F2]The shares are held in the name of the Eric Ostertag Living Trust dated March 30, 2016, of which the reporting person is the sole trustee.
- [F3]The shares are held in the name of Titan, LLC, which is owned by the Ostertag Descendents' Trust, of which the reporting person's minor daughter is the sole beneficiary. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F4]The shares are held in the name of Twin Prime Investments, an entity wholly owned by the reporting person.
- [F5]The shares are held in the name of the Ostertag Family Trust dated March 30, 2016, of which the reporting person is a trustee.
- [F6]The shares are held in the name of Transposagen Biopharmaceuticals, Inc., of which Dr. Ostertag is a majority stockholder.
- [F7]12.5% of the shares originally subject to the stock option vested and became exercisable on August 4, 2021, and the remaining shares vest in 42 equal monthly installments thereafter.
Documents
Issuer
Poseida Therapeutics, Inc.
CIK 0001661460
Entity typeother
Related Parties
1- filerCIK 0001765987
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 6:59 PM ET
- Size
- 12.0 KB